HMS Holdings Corp. HMSY reported adjusted earnings of 28 cents per share in first-quarter 2019, which surpassed the Zacks Consensus Estimate of 22 cents by 27.3%. The bottom line also soared 64.7% from the year-ago quarter.
Revenues totaled $147.9 million, which beat the Zacks Consensus Estimate by nearly 3%. Moreover, the top line improved 4.6% on a year-over-year basis.
Q1 Segmental Analysis by Product
Revenues at this segment were $42.1 million in the first quarter, down 15.3% year over year.
Within Analytical Services, PI revenues (excluding Medicare RAC) amounted to $27.7 million, down 8.6% year over year.
TPM revenues totaled $14.4 million in the quarter under review, reflecting an improvement of 30.9% on a year-over-year basis.
Revenues at the COB segment grossed $105.9 million in the first quarter, up 15.5% year over year.
Q1 Segmental Analysis by Market
Commercial revenues in the first quarter were $76.3 million, reflecting growth of 6.3% on a year-over-year basis.
State government revenues amounted to $61.7 million, which climbed 13% year over year.
Federal and Other revenues totaled $10 million in the quarter, down 33.3% year over year.
HMS Holdings Corp Price, Consensus and EPS Surprise
HMS Holdings Corp Price, Consensus and EPS Surprise | HMS Holdings Corp Quote
Total cost of services in the reported quarter was $99 million, up 1.5% year over year.
Adjusted gross profit came in at $48.9 million, up 11.5% from the prior-year quarter figure. Adjusted gross margin was 33.1% of net revenues, up 200 bps year over year.
Selling, general and administrative expenses totaled $29.2 million, down 8.6% year over year. Operating income in the first quarter was $19.7 million, up 65.3% on a year-over-year basis. Operating margin in the quarter was 13.3% of net revenues, up 490 bps.
Cash and cash equivalents amounted to $214.5 million, up 19.8% from the year-end 2018.
Net cash provided by operating activities for the three months ended Mar 31, 2019, came in at $23.1 million, surging 57.1% from the year-ago quarter.
The company has not provided any update regarding its previously-provided guidance for the full-year 2019. Notably, the company had issued a guidance for the full year 2019 during the fourth quarter earnings call.
For 2019, the company anticipates revenues between $640 million and $650 million. This depicts year-over-year growth in the band of 8.4-10.2%. The mid-point of $645 million is above the Zacks Consensus Estimate of $636.8 million.
Net income is expected in the band of $64-$70 million, indicating growth in the range of 27.2-39.2% year over year.
Adjusted EBITDA is expected in the range of $170-$175 million, reflecting growth of 9-12.2%.
Currently, HMS Holdings carries a Zacks Rank #3 (Hold).
Earnings of MedTech Majors at a Glance
Some better-ranked stocks which reported solid results this earning season are Stryker Corporation SYK, Abbott Laboratories ABT and CONMED Corporation CNMD, each carrying a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Stryker delivered first-quarter 2019 adjusted earnings per share of $1.88, beating the Zacks Consensus Estimate by 2.2%. Revenues of $3.52 billion were in line with the Zacks Consensus Estimate.
Abbott reported first-quarter 2019 adjusted earnings of 63 cents per share, beating the Zacks Consensus Estimate by 3.3%. First-quarter worldwide sales came in at $7.54 billion, above the Zacks Consensus Estimate of $7.47 billion.
CONMED posted first-quarter 2019 adjusted earnings per share of 57 cents, which beat the Zacks Consensus Estimate of 54 cents. Revenues were $218.4 million, surpassing the Zacks Consensus Estimate of $213 million.
Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Click to get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HMS Holdings Corp (HMSY) : Free Stock Analysis Report
Abbott Laboratories (ABT) : Free Stock Analysis Report
Stryker Corporation (SYK) : Free Stock Analysis Report
CONMED Corporation (CNMD) : Free Stock Analysis Report
To read this article on Zacks.com click here.